37 Results for "

MB-468

" in MedChemExpress (MCE) Product Catalog:
Products (37)

37 Results for "MB-468" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-11038
CAS No.: 873436-91-0
Purity:  99.93%
Synonyms: PU-H71
Target:  

HSP

Research Areas:  

Cancer

Zelavespib (PU-H71) is a potent Hsp90 inhibitor, with an IC50 of 51 nM in MDA-MB-468 cells.
loading...
    loading...
13
13 Publications Verification
Cat. No.: HY-11038B
CAS No.: 2095432-24-7
Purity:  98.89%
Synonyms: PU-H71 hydrochloride
Target:  

HSP

Research Areas:  

Cancer

Zelavespib (PU-H71) hydrochloride is a potent Hsp90 inhibitor, with an IC50 of 51 nM in MDA-MB-468 cells.
loading...
    loading...
13
13 Publications Verification
Cat. No.: HY-11038D
Purity:  97.39%
Synonyms: PU-H71 formic
Target:  

HSP

Research Areas:  

Cancer

Zelavespib formic (PU-H71 formic) is a potent Hsp90 inhibitor with an IC50 value of 51 nM for Hsp90 in MDA-MB-468 cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-110088
CAS No.: 922150-11-6
Purity:  99.73%
Target:  

MDM-2/p53

Research Areas:  

Cancer

SCH529074 is a potent and orally active p53 activator. SCH529074 binds specifically and conformation-dependently to p53 DBD ( DNA binding domain) with a Ki of 1-2 μM in a saturable manner. SCH529074 restores mutant p53 function and interrupts HDM2-mediated ubiquitination of wild Type p53. SCH529074 can be used for the study of non-small-cell lung carcinoma (NSCLC) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-117154
CAS No.: 1587705-63-2
Purity:  99.89%
Target:  

NEKs

Research Areas:  

Cancer

INH154 is a highly potent inhibitor for Nek2 and Hec1 binding (INH), with IC50s of 200 nM and 120 nM for INH in Hela and MB468 cells.
loading...
    loading...
Cat. No.: HY-112338
CAS No.: 823828-18-8
Purity:  98.29%
Synonyms: CPD188
Target:  

STAT Apoptosis

Research Areas:  

Cancer

C188 (CPD188) is a STAT3 inhibitor with anticancer effects. C188 inhibits STAT3 SH2/pY-peptide binding (IC50 of 20 µM against pY-peptide binding) and IL-6-mediated STAT3 phosphorylation. C188 is selective for STAT3 over STAT1. C188 inhibits nuclear-to-cytoplasmic translocation of Stat3. C188 shows highly active induces apoptosis in breast cancer cell lines with constitutive Stat3 activation (EC50s of 0.73 µM, 3.96 µM, and 7.01 µM in MDA-MB-468, MDA-MB-231, and MDA-MB-435 cultures, respectively) .
loading...
    loading...
Cat. No.: HY-161456
CAS No.: 17402-86-7
Research Areas:  

Cancer

PHGDH-IN-5 (Compound B12) is a covalen inhibitor of PHGDH with an IC50 value of 0.29 μM. PHGDH-IN-5 can inhibit cell proliferation in cancer cell lines overexpressing PHGDH. PHGDH-IN-5 can reduce the production of serine derived from glucose in MDA-MB-468 cells .
loading...
    loading...
Cat. No.: HY-115605
CAS No.: 375826-84-9
Research Areas:  

Cancer

CN009543V is an epidermal growth factor receptor (EGFR) agonist. CN009543V enhances tyrosine phosphorylation of EGFR at Tyr1068 and Tyr1173, thereby activating the MAPK/ERK cascade. CN009543V inhibits the activity of PTP-1B in MDA MB468 cells. CN009543V can be used in cancer research .
loading...
    loading...
Cat. No.: HY-N8187
CAS No.: 2170228-67-6
Eupalinolide O is a sesquiterpene lactone with anticancer activities. Eupalinolide O induces cell apoptosis in human MDA-MB-468 breast cancer cells .
loading...
    loading...
Cat. No.: HY-155787
CAS No.: 3054791-71-5
Target:  

CDK

Research Areas:  

Cancer

SHR5428 is a potent, orally active, selective and noncovalent inhibitor of CDK7 with highly potent CDK7 enzymatic activity (IC50=2.3 nM). SHR5428 inhibits triple negative breast cancer cellular activity on MDA-MB-468 cell (IC50=6.6 nM) .
loading...
    loading...
Cat. No.: HY-145860
Research Areas:  

Cancer

PHGDH-IN-2 is a potent and NAD + competitive PHGDH inhibitor with an IC50 of 5.2 µM. PHGDH-IN-2 inhibits the serine synthetic pathway in MDA-MB-468 cells. PHGDH-IN-2 inhibits the growth of PHGDH-dependent cancer cells .
loading...
    loading...
Cat. No.: HY-158170
CAS No.: 3034082-58-8
Target:  

CDK

Research Areas:  

Cancer

CDK7-IN-28 (CDK7-1276) is a potent CDK7 inhibitor(IC50<5 nM). CDK7-IN-28 can inhibit proliferation of MDA-MB-468 cell line by blocking cell cycle and inhibiting DNA replication .
loading...
    loading...
Cat. No.: HY-143293
CAS No.: 2874264-13-6
Target:  

VEGFR Apoptosis

Research Areas:  

Cancer

VEGFR-IN-3 (compound 3f) is a VEGFR inhibitor. VEGFR-IN-3 inhibits OVCAR-4 and MDA-MB-468 cancer cells growth with IC50s of 0.29 and 0.35 μM, respectively. VEGFR-IN-3 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-176549
CAS No.: 1996673-44-9
Target:  

RAD51

Research Areas:  

Cancer

(Rac)-IBR120 is the racemate of IBR120 (HY-176549A). IBR120 is a RAD51 inhibitor that has significant growth inhibition activity against MDA-MB-468 cells. (Rac)-IBR120 can be used for the research of difficult-to-treat cancers like triple negative breast cancer .
loading...
    loading...
Cat. No.: HY-172957
Target:  

JAK

Research Areas:  

Cancer

JNN-5 is a potent and selective JAK2 inhibitor with an IC50 of 0.41 nM. JNN-5 shows strong antiproliferative activities in the TNBC cell lines (MDA-MB-468, MDA-MB-213, HCC70, MDA-MB-157) .
loading...
    loading...
Cat. No.: HY-159990
CAS No.: 3032966-42-7
Research Areas:  

Cancer

GPX4-IN-15 (Compound C1) is an inhibitor for GPX4, that inhibits 19.8% GPX4 at 1 μM. GPX4-IN-15 inhibits the proliferation of cancer cell MDA-MB-468, BT-549 and MDA-MB-231 with IC50 of 0.86, 0.96 and 0.48 μM .
loading...
    loading...
Cat. No.: HY-174828
Target:  

PARP ATM/ATR Apoptosis

Research Areas:  

Cancer

ATR/PARP1-IN-1 is a potent ATR and PARP1 dual inhibitor with IC50s of 17.3 nM and 0.38 nM, respectively. ATR/PARP1-IN-1 effectively reduces cell viability, induces apoptosis and DNA damage. ATR/PARP1-IN-1 significantly impairs triple-negative breast cancer (TNBC) colony formation, migration, and invasion. ATR/PARP1-IN-1 suppresses tumor growth effectively in MDA-MB-468 xenografted mice, with no significant body weight change .
loading...
    loading...
Cat. No.: HY-101447
CAS No.: 223788-33-8
Synonyms: EPH 116
Target:  

Src Apoptosis

Research Areas:  

Cancer

SI-2 (EPH 116) is an inhibitor for steroid receptor coactivator-3 (SRC-3), which reduces the transcriptional activity and protein concentration of SRC-3 in cells, exhibits cytotoxicity in cancer cell, inhibits migration of MDA-MB-468, induces apoptosis of MDA-MB-468. SI-2 inhibits the tumor growth in mouse models, without significant toxicity for heart and other major organs (20 mg/kg) .
loading...
    loading...
Cat. No.: HY-10062
CAS No.: 345915-10-8
Synonyms: EBP-921
Research Areas:  

Cancer

AZD3409 is a prenyl inhibitor that exhibits inhibitory activity against both farnesyl transferase and geranylgeranyl transferase I. AZD3409 inhibits the growth of breast cancer cells, with IC50s of 220 nM (MDA-MB-468), 180 nM (MDA-MB-361), and 290 nM (SK-Br-3). AZD3409 significantly reduces the activation level of AKT in breast cancer cell lines. AZD3409 induces G0/G1 phase arrest in MDA-MB-468 cells, causes G2/M phase arrest in MDA-MB-361 cells. AZD3409 can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-160598
CAS No.: 2891774-71-1
Research Areas:  

Cancer

Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol (compound 45) is a camptothecin compound that can inhibit cell proliferation, with an IC50 of 2.92 ng/mL for MDAMB‑468 cells. Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol can be used for the research of cancer .
loading...
    loading...